Schedule 13G ownership disclosure

Hancock Jaffe Laboratories, Inc.

Security class unavailable · CUSIP: 41015N106

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,478,581
Percent of class
38.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-19-002124
Form type
SC 13G
Filer
enVVeno Medical Corp
CIK
CIK 1661053
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub